QIPT — Quipt Home Medical Share Price
0.000.00%
Last trade - 00:00- $93.55m
- $178.82m
- $245.92m
- 56
- 93
- 17
- 56
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.88 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 4.32 | ||
| Price to Sales | 0.39 | ||
| EV to EBITDA | 4.12 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.1% | ||
| Return on Equity | -6.69% | ||
| Operating Margin | 0.08% | ||
Financial Summary
| Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 72.64 | 102.35 | 139.86 | 211.68 | 245.91 | 249.79 | 263.25 | 32.15% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Quipt Home Medical Corp. is a home medical equipment provider. The Company provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. The Company’s comprehensive solutions support patients dealing with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. The Company serves patients approximately 26 states in the United States. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, home medical equipment, and custom mobility solutions.
Directors
- Gregory Crawford CHM
- Hardik Mehta CFO
- Robbie Grossman SEC
- Kevin Carter IND
- Mark Greenberg IND
- Brian Wessel IND
- Last Annual
- September 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 21st, 2017
- Public Since
- March 18th, 2014
- No. of Employees
- 1,200
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 43,091,273
- Address
- 1019 TOWN DRIVE, WILDER, 41076
- Web
- https://quipthomemedical.com/
- Phone
- +1 8598782220
- Contact
- Cole Stevens
- Auditors
- BDO USA, LLP
Upcoming Events for QIPT
Q2 2025 Quipt Home Medical Corp Earnings Call
Q3 2025 Quipt Home Medical Corp Earnings Release
Q3 2025 Quipt Home Medical Corp Earnings Release
Similar to QIPT
ADVANCED BIOMED
NASDAQ Capital Market
IMEI Technology Health
NASDAQ Capital Market
Akanda
NASDAQ Capital Market
Astrana Health
NASDAQ Capital Market
Basel Medical
NASDAQ Capital Market
FAQ
What is the Quipt Home Medical share price?
As of Today at 22:50 UTC, shares in Quipt Home Medical are trading at $2.17. This share price information is delayed by 15 minutes.
How has the Quipt Home Medical share price performed this year?
Shares in Quipt Home Medical last closed at $2.17 and the price had moved by -45.89% over the past 365 days. In terms of relative price strength the Quipt Home Medical share price has underperformed the S&P500 Index by -51.2% over the past year.
What are the analyst and broker recommendations for Quipt Home Medical?
The overall consensus recommendation for Quipt Home Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Quipt Home Medical dividend yield?
Quipt Home Medical does not currently pay a dividend.
Does Quipt Home Medical pay a dividend?
Quipt Home Medical does not currently pay a dividend.
When does Quipt Home Medical next pay dividends?
Quipt Home Medical does not currently pay a dividend.
How do I buy Quipt Home Medical shares?
To buy shares in Quipt Home Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Quipt Home Medical?
As of the previous close price of $2.17, shares in Quipt Home Medical had a market capitalisation of $93.55m.
Where are Quipt Home Medical shares listed?
Here are the trading details for Quipt Home Medical:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: QIPT
What kind of share is Quipt Home Medical?
Based on an overall assessment of its quality, value and momentum Quipt Home Medical is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Quipt Home Medical share price forecast for 2025?
The analyst consensus target price for shares in Quipt Home Medical is $6.15. That is 183.2% above the last closing price of $2.17.
Analysts covering Quipt Home Medical currently have a consensus Earnings Per Share (EPS) forecast of -$0.08 for the next financial year.
Find out moreWhat is the trend in the Quipt Home Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Quipt Home Medical. Over the past six months, its share price has underperformed the S&P500 Index by -17.11%.
As of the last closing price of $2.17, shares in Quipt Home Medical were trading -20.91% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Quipt Home Medical PE Ratio?
The Quipt Home Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.17.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Quipt Home Medical?
Quipt Home Medical's management team is headed by:
- Gregory Crawford - CHM
- Hardik Mehta - CFO
- Robbie Grossman - SEC
- Kevin Carter - IND
- Mark Greenberg - IND
- Brian Wessel - IND